Two doses of BNT162b2 SARS-CoV-2 vaccine highly effective
New antibody rationally designed for better tumor inhibition
7 May 2021EU sceptical of US push to lift COVID vaccine patents
7 May 2021Two doses of BNT162b2 SARS-CoV-2 vaccine highly effective
Two doses of BNT162b2 are highly effective for preventing symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and other outcomes, according to a study published online May 5 in The Lancet.
